Sustained telomere erosion due to increased stem cell turnover during triple autologous hematopoietic stem cell transplantation

Experimental Hematology

Volumn 36, Issue 1, 2008, Pages 104-110

  Widmann, Thomas ^a   Kneer, Harald ^a   König, Jochem ^b   Herrmann, Markus ^a   Pfreundschuh, Michael ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB; VINCRISTINE;

ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER THERAPY; CELL DIVISION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HUMAN; KINETICS; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; STEM CELL; TELOMERE;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL AGING; CELL DIVISION; CLINICAL TRIALS, PHASE III AS TOPIC; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTES; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOCYTES; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; MYELOPOIESIS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PREDNISOLONE; PROSPECTIVE STUDIES; TELOMERE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; VINCRISTINE;

EID: 37249078012     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2007.08.028     Document Type: Article

References (43)

1. Allsopp R.C., Vaziri H., Patterson C., et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A 89 (1992) 10114-10118
2. Rufer N., Brummendorf T.H., Kolvraa S., et al. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med 190 (1999) 157-167
3. Schonland S.O., Widmann T., Lopez-Benitez C.M., et al. Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci U S A 100 (2003) 13471-13476
4. Beier F., Balabanov S., Buckley T., et al. Accelerated telomere shortening in glycosylphosphatidylinositol (GPI)-negative compared with GPI-positive granulocytes from patients with paroxysmal nocturnal hemoglobinuria (PNH. detected by proaerolysin flow-FISH. Blood 106 (2005) 531-533
5. Brummendorf T.H., Holyoake T.L., Rufer N., et al. Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry. Blood 95 (2000) 1883-1890
6. Vogt S., Iking-Konert C., Hug F., Andrassy K., and Hansch G.M. Shortening of telomeres: Evidence for replicative senescence of T cells derived from patients with Wegener's granulomatosis. Kidney Int 63 (2003) 2144-2151
7. Crabbe L., Verdun R.E., Haggblom C.I., and Karlseder J. Defective telomere lagging strand synthesis in cells lacking WRN helicase activity. Science 306 (2004) 1951-1953
8. Metcalfe J.A., Parkhill J., Campbell L., et al. Accelerated telomere shortening in ataxia telangiectasia. Nat Genet 13 (1996) 350-353
9. Vulliamy T., Marrone A., Dokal I., and Mason P.J. Association between aplastic anaemia and mutations in telomerase RNA. Lancet 359 (2002) 2168-2170
10. Vulliamy T., Marrone A., Goldman F., et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413 (2001) 432-435
11. Epel E.S., Blackburn E.H., Lin J., et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A 101 (2004) 17312-17315
12. Von Zglinicki T., Petrie J., and Kirkwood T.B. Telomere-driven replicative senescence is a stress response. Nat Biotechnol 21 (2003) 229-230
13. Widmann T.A., Herrmann M., Taha N., Konig J., and Pfreundschuh M. Short telomeres in aggressive non-Hodgkin's lymphoma as a risk factor in lymphomagenesis. Exp Hematol 35 (2007) 939-946
14. Fitzpatrick A.L., Kronmal R.A., Gardner J.P., et al. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol 165 (2007) 14-21
15. Von Zglinicki T., Serra V., Lorenz M., et al. Short telomeres in patients with vascular dementia: an indicator of low antioxidative capacity and a possible risk factor?. Lab Invest 80 (2000) 1739-1747
16. Lee J.J., Nam C.E., Cho S.H., et al. Telomere length shortening in non-Hodgkin's lymphoma patients undergoing chemotherapy. Ann Hematol 82 (2003) 492-495
17. Akiyama M., Asai O., Kuraishi Y., et al. Shortening of telomeres in recipients of both autologous and allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 25 (2000) 441-447
18. Bhatia R., Van Heijzen K., Palmer A., et al. Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphoma. J Clin Oncol 23 (2005) 6699-6711
19. Rufer N., Brummendorf T.H., Chapuis B., et al. Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation. Blood 97 (2001) 575-577
20. Roelofs H., de Pauw E.S., Zwinderman A.H., et al. Homeostasis of telomere length rather than telomere shortening after allogeneic peripheral blood stem cell transplantation. Blood 101 (2003) 358-362
21. Wynn R.F., Cross M.A., Hatton C., et al. Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. Lancet 351 (1998) 178-181
22. Glass B., Kloess M., Bentz M., et al. Dose-escalated CHOP plus etoposide (MegaCHOEP. followed by repeated stem cell transplantation for primary treatment of aggressive high-risk non-Hodgkin lymphoma. Blood 107 (2006) 3058-3064
23. Lotz J.P., Bui B., Gomez F., et al. Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial. Ann Oncol 16 (2005) 411-418
24. Elias A.D., Ibrahim J., Richardson P., et al. The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program. Biol Blood Marrow Transplant 8 (2002) 198-205
25. Awaya N., Baerlocher G.M., Manley T.J., et al. Telomere shortening in hematopoietic stem cell transplantation: a potential mechanism for late graft failure?. Biol Blood Marrow Transplant 8 (2002) 597-600
26. Shipp M.A. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329 (1993) 987-994
27. Widmann T.A., Willmann B., Pfreundschuh M., and Beelen D.W. Influence of telomere length on short-term recovery after allogeneic stem cell transplantation. Exp Hematol 33 (2005) 1257-1261
28. Thornley I., Sutherland R., Wynn R., et al. Early hematopoietic reconstitution after clinical stem cell transplantation: evidence for stochastic stem cell behavior and limited acceleration in telomere loss. Blood 99 (2002) 2387-2396
29. Ricca I., Compagno M., Ladetto M., et al. Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF. Leukemia 19 (2005) 644-651
30. Notaro R., Cimmino A., Tabarini D., Rotoli B., and Luzzatto L. In vivo telomere dynamics of human hematopoietic stem cells. Proc Natl Acad Sci U S A 94 (1997) 13782-13785
31. Allsopp R.C., Cheshier S., and Weissman I.L. Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells. J Exp Med 193 (2001) 917-924
32. Benboubker L., Cartron G., Roingeard F., et al. Long-term marrow reconstitutive ability of autologous grafts in lymphoma patients using peripheral blood mobilized with granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor compared to bone marrow. Exp Hematol 31 (2003) 89-97
33. Robertson J.D., Testa N.G., Russell N.H., et al. Accelerated telomere shortening following allogeneic transplantation is independent of the cell source and occurs within the first year post transplant. Bone Marrow Transplant 27 (2001) 1283-1286
34. Passegue E., Wagers A.J., Giuriato S., Anderson W.C., and Weissman I.L. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J Exp Med 202 (2005) 1599-1611
35. Lacorazza H.D., Yamada T., Liu Y., et al. The transcription factor MEF/ELF4 regulates the quiescence of primitive hematopoietic cells. Cancer Cell 9 (2006) 175-187
36. Roux E., Dumont-Girard F., Starobinski M., et al. Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity. Blood 96 (2000) 2299-2303
37. Dumont-Girard F., Roux E., van Lier R.A., et al. Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants. Blood 92 (1998) 4464-4471
38. Allsopp R.C., Morin G.B., Horner J.W., et al. Effect of TERT over-expression on the long-term transplantation capacity of hematopoietic stem cells. Nat Med 9 (2003) 369-371
39. Allsopp R.C., Morin G.B., DePinho R., Harley C.B., and Weissman I.L. Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood 102 (2003) 517-520
40. Serke S., and Johnsen H.E. A European reference protocol for quality assessment and clinical validation of autologous haematopoietic blood progenitor and stem cell grafts. Bone Marrow Transplant 27 (2001) 463-470
41. Domenech J., Roingeard F., Herault O., et al. Changes in the functional capacity of marrow stromal cells after autologous bone marrow transplantation. Leuk Lymphoma 29 (1998) 533-546
42. Goytisolo F.A., Samper E., Martin-Caballero J., et al. Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals. J Exp Med 192 (2000) 1625-1636
43. Rudolph K.L., Chang S., Lee H.W., et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96 (1999) 701-712